tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD
US Market

Opus Genetics (IRD) Financial Statements

Compare
1,264 Followers

Opus Genetics Financial Overview

Opus Genetics's market cap is currently $325.86M. The company's EPS TTM is $-0.19; its P/E ratio is -25.22; Opus Genetics is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 14.20M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Gross Profit$ 14.14M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Operating Income$ -38.60M$ -62.07M$ -10.56M$ 18.23M$ -22.70M
EBITDA$ -38.60M$ -57.52M$ -9.97M$ 18.22M$ -56.69M
Net Income$ -49.59M$ -57.53M$ -9.99M$ 17.89M$ -56.69M
Balance Sheet
Cash & Short-Term Investments$ 45.09M$ 30.32M$ 50.52M$ 42.68M$ 24.75M
Total Assets$ 50.24M$ 36.86M$ 53.95M$ 48.99M$ 26.08M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 538.00K
Net Debt$ -45.09M$ -30.32M$ -50.50M$ -42.63M$ -24.00M
Total Liabilities$ 34.90M$ 30.14M$ 4.04M$ 2.75M$ 3.85M
Stockholders' Equity$ 15.35M$ 6.72M$ 49.91M$ 46.24M$ 22.22M
Cash Flow
Free Cash Flow$ -35.25M$ -25.58M$ -1.11M$ 14.31M$ -19.37M
Operating Cash Flow$ -35.25M$ -25.58M$ -1.11M$ 14.31M$ -19.37M
Investing Cash Flow$ 0.00$ 1.21M$ 0.00$ 0.00$ -100.00K
Financing Cash Flow$ 50.02M$ 4.19M$ 8.98M$ 3.79M$ 27.61M
Currency in USD

Opus Genetics Earnings and Revenue History

Opus Genetics Debt to Assets

Opus Genetics Cash Flow

Opus Genetics Forecast EPS vs Actual EPS